Tag: Galectin Therapeutics Inc.

Business

Galectin Therapeutics Inc (NASDAQ: GALT) Has Dropped -16.57% So Far This Year. Does That Mean Trouble Ahead?

During the last session, Galectin Therapeutics Inc (NASDAQ:GALT)’s traded shares were 0.52 million, with the beta value of the company hitting 0.74. At the end

Company

Galectin Therapeutics Inc (NASDAQ: GALT): Stock Forecast For 2025 Remains Weak With A Downward Revision Of 35.3%

In the last trading session, 0.23 million shares of the Galectin Therapeutics Inc (NASDAQ:GALT) were traded, and its beta was 0.82. Most recently the company’s

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: Galectin Therapeutics Inc.

Galectin Therapeutics Inc (NASDAQ: GALT) Has Dropped -16.57% So Far This Year. Does That Mean Trouble Ahead?

Galectin Therapeutics Inc (NASDAQ: GALT): Stock Forecast For 2025 Remains Weak With A Downward Revision Of 35.3%

Quick Links

Categories